The Choosing Wisely campaign, lists of services developed by physicians’ specialty societies, is a good start to spark discussion between physicians their patients about treatments and tests that may not be warranted.
Dartmouth Medicine asked geneticist Jason Moore about his thoughts on the FDA’s decision to order 23andMe, a company that provides personal genetic testing, to stop selling its genetic test for health-related purposes.
I sheepishly make my way through the crowded, chaotic waiting room of Friend Family Health Center, one of the free primary care clinics here on Chicago’s South Side.
The keynote speaker, a slight, dignified, gray-haired woman, made her way to the podium. Now retired, she had long been a respected and beloved physician.